In ESCC, for example, CXCL10 expression inhibits cancer cell invasion and promotes migration of immune cells to the cancer microenvironment, suggesting CXCL10 exerts an inhibitory effect on ESCC progression [26, 27]. This evidence concerns the gene CXCL10 and esophageal squamous cell carcinoma.